Skip to content

Personalis, Inc. PSNL EBITDA margin

EBITDA margin at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
19.4%+0.6pp
NeoGenomics logo
NeoGenomicsNEO
-5.3%-85.9pp
Illumina logo
IlluminaILMN
25.5%
Veracyte logo
VeracyteVCYT
18.3%+8.1pp
Guardant Health logo
Guardant HealthGH
-37.8%-8.5pp
Natera, Inc. logo
Natera, Inc.NTRA
-11.1%+0.5pp

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.19B+115%
Enterprise value$1.16B+125%
P/S18.4×+12.0×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Calculated from Personalis, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s EBITDA margin?
Personalis, Inc. (PSNL) reported EBITDA margin of -143.7% in Q1 2026.
How has Personalis, Inc.'s EBITDA margin changed year-over-year?
Personalis, Inc.'s EBITDA margin decreased by 118.6% year-over-year, from -65.8% to -143.7%.
What is the long-term trend for Personalis, Inc.'s EBITDA margin?
Over 5 years (2020 to 2025), Personalis, Inc.'s EBITDA margin has grown at a 19.4% compound annual growth rate (CAGR), from -46.2% to -112.1%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.